Literature DB >> 30498617

Hepatitis B vaccination in Nepalese infants: The present scenario.

Sudhir Adhikari1, Brijesh Sathian2.   

Abstract

Entities:  

Year:  2017        PMID： 30498617      PMCID： PMC6170029          DOI： 10.3126/nje.v7i3.19007

Source DB:  PubMed          Journal:  Nepal J Epidemiol


× No keyword cloud information.
  5 in total

Review 1.  Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.

Authors:  Maria Machaira; Vassiliki Papaevangelou; Evridiki K Vouloumanou; Giannoula S Tansarli; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2014-10-31       Impact factor: 5.790

2.  Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal.

Authors:  Shyam Raj Upreti; Santosh Gurung; Minal Patel; Sameer M Dixit; L Kendall Krause; Geeta Shakya; Kathleen Wannemuehler; Rajesh Rajbhandari; Rajendra Bohara; W William Schluter
Journal:  Vaccine       Date:  2014-06-18       Impact factor: 3.641

3.  Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.

Authors:  Michelle M Hughes; Joanne Katz; Janet A Englund; Subarna K Khatry; Laxman Shrestha; Steven C LeClerq; Mark Steinhoff; James M Tielsch
Journal:  Vaccine       Date:  2016-01-11       Impact factor: 3.641

4.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2017.

Authors:  Candice L Robinson; José R Romero; Allison Kempe; Cynthia Pellegrini
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-10       Impact factor: 17.586

5.  Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal.

Authors:  Purusotam Raj Shedain; Madhu Dixit Devkota; Megha Raj Banjara; Huang Ling; Subash Dhital
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.